Poseida Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Poseida Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Poseida Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $4.96M, a 3.09% decline year-over-year.
  • Poseida Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $23M, a 1.84% increase year-over-year.
  • Poseida Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $23.1M, a 22.2% increase from 2022.
  • Poseida Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $18.9M, a 13.3% increase from 2021.
  • Poseida Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $16.7M, a 131% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $23.1M +$4.21M +22.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $18.9M +$2.22M +13.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $16.7M +$9.48M +131% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $7.22M +$4.17M +137% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $3.05M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.